Infiniplex(אינפיניפלקס בע~מ)
Yokne'am Illit, Israel
Infiniplex is developing an ultra-specific, multiplexed qPCR/dPCR-based liquid biopsy platform for precision oncology. From a simple liquid biopsy sample- primarily plasma and urine - our technology can pick dozens of cancer mutations in 2-3 hours at 0.01-0.1% VAF, enabling real-time CDx (companion diagnostics), treatment monitoring, and MRD characterization use cases with NGS sensitivity and at PCR speed, cost, and accessibility.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.infiniplex.life
Only accessible to MedStartr community members.
Join nowWhat do you think of Infiniplex(אינפיניפלקס בע~מ)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now